Equities

Integer Holdings Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Integer Holdings Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)85.92
  • Today's Change0.56 / 0.66%
  • Shares traded929.71k
  • 1 Year change-38.04%
  • Beta0.7431
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation.

  • Revenue in USD (TTM)1.83bn
  • Net income in USD87.20m
  • Incorporated1997
  • Employees11.00k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Omnicell Inc1.18bn2.05m1.64bn3.60k844.321.3320.011.380.04320.043225.7027.450.57867.195.01--0.10020.73310.13570.976742.4944.800.17321.321.22--0.1198--6.535.84-83.62-42.341.93--
AxoGen Inc214.71m-2.10m1.67bn451.00--12.69343.247.76-0.0486-0.04864.562.621.051.557.75476,073.20-1.03-11.36-1.17-13.0574.7678.42-0.9767-15.372.640.64930.2852--17.8111.9154.12---2.84--
Inspire Medical Systems Inc911.98m145.42m1.71bn1.33k12.022.1910.711.874.974.9730.7527.331.061.188.57684,156.8016.953.0919.003.4885.3984.8315.953.054.56--0.000.0013.6051.21171.77--73.41--
Artivion Inc422.65m-9.12m1.75bn1.60k--3.95126.384.14-0.242-0.2429.489.260.5091.725.16264,153.80-1.10-2.47-1.29-2.6664.5065.02-2.16-5.892.881.290.3324--9.757.0656.37--6.75--
Heartflow Inc-100.00bn-100.00bn1.76bn699.00--6.77----------3.05----------------------------0.00--44.32--22.04------
UFP Technologies Inc597.95m67.12m1.90bn4.15k28.544.6922.063.178.618.6176.7152.370.92614.896.86144,223.8010.4010.1211.8711.5328.5127.0711.2310.641.368.390.26570.0026.0820.5231.2924.4610.82--
Alphatec Holdings Inc728.02m-154.96m1.98bn867.00--173.41--2.73-1.05-1.054.910.23510.94971.287.90839,700.10-20.21-27.43-26.81-34.6969.2366.99-21.29-39.401.24-1.860.941--26.8140.0713.14--48.19--
LeMaitre Vascular Inc240.87m53.34m1.99bn651.0038.415.2531.258.262.282.2810.3516.710.4941.037.45369,993.8010.949.0911.699.8970.9766.2422.1416.6411.45--0.307738.3813.6313.4046.2819.6813.1115.91
Establishment Labs Holdings Inc190.97m-82.98m2.17bn1.02k--132.47--11.35-2.84-2.846.530.56320.61450.7692.75187,596.30-26.70-31.53-33.25-39.3268.7465.46-43.45-45.092.10-1.720.9377--0.529213.14-7.76--17.33--
10X Genomics Inc642.82m-43.54m2.31bn1.18k--2.91--3.60-0.3496-0.34965.156.240.65592.859.53545,690.10-4.44-14.35-5.16-16.4369.1372.27-6.77-24.504.09--0.00--5.2516.5576.16---31.16--
Neogen Corp880.32m-602.74m2.38bn2.97k--1.13--2.70-2.78-2.784.059.670.23752.635.95296,005.00-16.26-7.73-16.94-8.0645.9848.10-68.47-27.912.80-0.21090.2737---3.2016.43-11,491.59--34.18--
DENTSPLY SIRONA Inc3.62bn-882.00m2.58bn14.00k--1.75--0.7131-4.43-4.4318.187.410.59032.725.47258,857.10-14.35-4.06-18.88-4.8351.1053.14-24.31-8.590.98659.680.6184---4.34-1.17-589.39--7.9111.28
Haemonetics Corp1.32bn175.44m2.68bn3.02k15.872.979.322.043.643.6427.4019.460.5251.586.47436,081.706.995.418.306.5559.3253.2013.319.181.1512.690.57330.003.956.6042.6416.994.37--
Integer Holdings Corp1.83bn87.20m3.01bn11.00k35.841.7214.251.642.402.3951.7649.830.55785.044.83166,461.302.663.282.843.5427.1526.704.766.382.455.230.41120.0010.356.4135.805.8216.99--
ICU Medical Inc2.32bn-7.36m3.58bn15.00k--1.6818.251.54-0.3109-0.310994.3086.170.5522.2412.70154,690.90-0.206-0.2042-0.2351-0.230636.4733.82-0.3731-0.33261.191.620.3829--5.4413.47-296.86---3.18--
LivaNova PLC1.35bn-217.49m3.59bn2.90k--3.10--2.66-4.01-4.0124.6421.190.53112.586.60465,159.30-8.56-4.14-11.07-5.0368.5067.61-16.12-9.041.1210.220.273--8.662.94260.39--10.98--
Data as of Feb 13 2026. Currency figures normalised to Integer Holdings Corp's reporting currency: US Dollar USD

Institutional shareholders

48.75%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 31 Dec 20254.87m13.89%
The Vanguard Group, Inc.as of 31 Dec 20253.60m10.26%
SSgA Funds Management, Inc.as of 31 Dec 20251.37m3.92%
Dimensional Fund Advisors LPas of 31 Dec 20251.31m3.73%
AllianceBernstein LPas of 30 Sep 20251.26m3.60%
EARNEST Partners LLCas of 31 Dec 20251.06m3.04%
Viking Global Investors LPas of 30 Sep 20251.02m2.93%
Invesco Advisers, Inc.as of 30 Sep 2025951.17k2.72%
Geode Capital Management LLCas of 31 Dec 2025832.91k2.38%
Massachusetts Financial Services Co.as of 31 Dec 2025806.98k2.30%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.